Catalyst Capital Advisors LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 265 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 1.06 and the average weighting 0.4%.

Quarter-by-quarter ownership
Catalyst Capital Advisors LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$796,000
-88.9%
8,000
-86.7%
0.03%
-98.0%
Q2 2016$7,156,000
-0.3%
60,000
-10.4%
1.32%
+9.5%
Q1 2016$7,175,000
-1.2%
67,0000.0%1.21%
+14.8%
Q4 2015$7,264,000
+26.6%
67,0000.0%1.05%
+36.6%
Q3 2015$5,739,000
+191.5%
67,000
+81.1%
0.77%
+233.3%
Q4 2014$1,969,000
+186.2%
37,000
+152.6%
0.23%
+159.6%
Q3 2014$688,00014,6470.09%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Knott David M Jr 115,000$6,8912.63%
VILLERE ST DENIS J & CO LLC 438,161$26,254,6072.24%
RICE HALL JAMES & ASSOCIATES, LLC 282,961$16,955,0231.08%
Chicago Capital, LLC 360,345$21,591,8841.01%
CARDINAL CAPITAL MANAGEMENT LLC /CT 206,399$12,367,4280.53%
Smith, Graham & Co., Investment Advisors, LP 61,849$3,705,9920.46%
Stephens Investment Management Group LLC 467,564$28,016,4350.46%
Jackson Creek Investment Advisors LLC 13,657$8180.34%
Court Place Advisors, LLC 15,133$906,7690.32%
Ziegler Capital Management, LLC 123,158$7,379,1760.30%
View complete list of LIGAND PHARMACEUTICALS INC shareholders